1. Home
  2. BDL vs ANVS Comparison

BDL vs ANVS Comparison

Compare BDL & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flanigan's Enterprises Inc.

BDL

Flanigan's Enterprises Inc.

N/A

Current Price

$30.50

Market Cap

62.6M

ML Signal

N/A

Logo Annovis Bio Inc.

ANVS

Annovis Bio Inc.

HOLD

Current Price

$2.14

Market Cap

69.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BDL
ANVS
Founded
1959
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
62.6M
69.1M
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
BDL
ANVS
Price
$30.50
$2.14
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$13.50
AVG Volume (30 Days)
1.2K
954.1K
Earning Date
05-18-2026
05-12-2026
Dividend Yield
1.90%
N/A
EPS Growth
49.72
39.39
EPS
1.98
N/A
Revenue
$205,248,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$15.40
N/A
Revenue Growth
8.99
N/A
52 Week Low
$22.61
$1.54
52 Week High
$35.98
$5.50

Technical Indicators

Market Signals
Indicator
BDL
ANVS
Relative Strength Index (RSI) 47.97 50.12
Support Level $28.82 $1.86
Resistance Level $33.69 $2.29
Average True Range (ATR) 1.46 0.17
MACD 0.07 0.03
Stochastic Oscillator 29.29 54.13

Price Performance

Historical Comparison
BDL
ANVS

About BDL Flanigan's Enterprises Inc.

Flanigan'S Enterprises Inc operates as a chain of small cocktail lounges and packages liquor stores throughout South Florida. The business activity is principally conducted in two segments namely Restaurant and Package liquor store segment. Its Restaurant segment offers alcoholic beverages and full food service, and Package stores consist of retail liquor sales and related items. Its menu consists of a wide variety of options including prime rib, steaks, pasta, entree salads, burgers, a variety of sandwiches, and oversized signature desserts. The company generates maximum revenue from Restaurant segment.

About ANVS Annovis Bio Inc.

Annovis Bio Inc, a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's flagship candidate, buntanetap, is in clinical trials for the treatment of Alzheimer's disease, Parkinson's disease, and Lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer's disease and dementia.

Share on Social Networks: